Intuitive Surgical, Inc. (ISRG) Performance:-18.93%(TTM)
The total return for Intuitive Surgical, Inc. (ISRG) stock is -18.93% over the past 12 months vs. +24.34% for the S&P 500. So far it's up -24.68% this year. Includes price appreciation + reinvested dividends.
Intuitive Surgical, Inc. (ISRG) Compound Annual Growth Rates (CAGR) Summary
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (18.93%) | +10.90% | +8.78% | +19.47% | +17.49% | +19.37% |
| Total Return CAGR | (18.93%) | +10.90% | +8.78% | +19.47% | +17.49% | +19.37% |
| Revenue CAGR | +21.44% | +18.06% | +18.39% | +15.77% | +14.05% | +20.29% |
| Net Income CAGR | +20.33% | +31.43% | +20.49% | +16.84% | +14.31% | +18.53% |
| EPS CAGR | +22.34% | +29.07% | +21.51% | +16.35% | +14.28% | +17.84% |
| Free Cash Flow CAGR | +62.45% | +41.14% | +16.61% | +13.70% | +13.61% | +23.53% |
| Operating Cash Flow CAGR | +23.07% | +27.03% | +15.87% | +14.65% | +13.35% | +20.98% |
| Dividends CAGR | - | - | - | - | - | - |
CAGR Trends History
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
ISRG Total Return CAGR Chart
Intuitive Surgical, Inc. (ISRG)
Annual Total Returns Comparison
| Year | Start Value | End Value | ISRG Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 27899.51 | 21015.27 | (24.68%) | +8.38% | (33.06%) |
| 2025 | 25712.32 | 27899.51 | +8.51% | +17.72% | (9.21%) |
| 2024 | 16618.72 | 25712.32 | +54.72% | +24.89% | +29.83% |
| 2023 | 13071.43 | 16618.72 | +27.14% | +26.19% | +0.95% |
| 2022 | 17699.51 | 13071.43 | (26.15%) | (18.17%) | (7.98%) |
| 2021 | 13433.50 | 17699.51 | +31.76% | +28.74% | +3.02% |
| 2020 | 9706.90 | 13433.50 | +38.39% | +18.37% | +20.02% |
| 2019 | 7864.04 | 9706.90 | +23.43% | +31.22% | (7.79%) |
| 2018 | 5992.61 | 7864.04 | +31.23% | (4.56%) | +35.79% |
| 2017 | 3470.94 | 5992.61 | +72.65% | +21.70% | +50.95% |
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa